The Impact of Ergonomic Circadian Light on Hospitalized Stroke Patients in a Rehabilitation Unit

NCT ID: NCT02186392

Last Updated: 2017-12-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-05-31

Study Completion Date

2016-08-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to investigate the impact of exposure to ergonomic circadian light on physiological and mental parameters in stroke patients admitted for rehabilitation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Stroke annually affects approximately 12,000 Danes and there are approximately 50,000 living persons with sequelae after stroke in Denmark. Stroke is the major cause of acquired cerebral disability among adults and the second most common cause of dementia and the third leading cause of death.

Besides the acute stroke treatment, an effective rehabilitation program is necessary for optimal recovery. A prerequisite for this is that stroke patients are able to contribute optimally to the training, however, changes in the sleep pattern and disturbed circadian rhythm may exert negative effects.

Little is known about circadian disturbances in relation to rehabilitations and which consequences it may have on the physiological and mental levels.

The investigators will investigate the following hypotheses:

A: Ergonomic circadian light improves well-being and fatigue in post-stroke patients compared with a control group receiving standard light facilities.

B: Ergonomic circadian light induces improve sleep-wake cycle and circadian rhythm in post-stroke patients compared with a control group receiving standard light facilities.

C: Ergonomic circadian light induces reduction in depression and anxiety in post-stroke patients compared with a control group receiving standard light facilities.

D: Ergonomic circadian light improves the cognitive function in post-stroke patients compared with a control group receiving standard light facilities.

E: Ergonomic circadian light induces reduction in autonomic dysfunction in post-stroke patients compared with a control group receiving standard light facilities.

F: Ergonomic circadian light will regulate circadian rhythm specific blood tests in post-stroke patients compared with a control group receiving standard light facilities.

From the acute stroke unit the patients will be random transferred to two rehabilitation units where the will be the intervention unit with the circadian light installed and a control unit with conventional light.

At the inclusion, patients will be assessed by the following interventions mentioned below, which again will be evaluated at discharge. The incompetent patients to these interventions must abstain.

The numbers of patients who are expected to be included are 110 calculated with 25% dropout resulting in approximately 80 patients.

All patients who are found suitable for admission to the two rehabilitation departments will be listed. If a patient is not suitable for inclusion in the study the reason will be described and published.

During hospitalization on the rehabilitation unit following tests/interventions will be performed on the patients:

* Stroke classification
* Sleep physiology
* Sleep biochemistry
* Test for depression
* Test for cognitive function
* Test for anxiety
* Test Fatigue
* Testing for sleep quality
* Test for Quality of well being
* Chronotype classification
* Autonomic dysfunction
* Status of physical rehabilitation
* Functional MRI Resting state
* Circadian blood samples
* Ophthalmological examination

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke Sleep Apnea Syndromes Depression Anxiety

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Depression Anxiety Stroke Cerebral Infarction Sleep disorders Circadian Rhythm disorders Circadian Light Light therapy Melatonin Sleep Sleep apnea Coagulation disturbances Bone metabolism Rehabilitation Mood disorders Mental disorders Neurologic Manifestations Signs and Symptoms Cerebrovascular Disorders Brain Diseases Vascular Disease Brain Infarction Brain Ischemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control department

The control department where the conventional light is installed.

Group Type NO_INTERVENTION

No interventions assigned to this group

Circadian Light luminaries

The department where the special circadian light is installed. The light is programmed to have the desired light intensity (lux), color temperature (Kelvin) and wavelength (nm) according to the knowledge about the phase-response curve.

Group Type EXPERIMENTAL

Circadian Light luminaries

Intervention Type DEVICE

The light is programmed to have the desired light intensity (lux), color temperature (Kelvin) and wavelength (nm) according to the knowledge about the phase-response curve.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Circadian Light luminaries

The light is programmed to have the desired light intensity (lux), color temperature (Kelvin) and wavelength (nm) according to the knowledge about the phase-response curve.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Chroma Viso Ergonomic

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients evaluated as candidates to the rehabilitation units from May 1th 2014 to May 1th 2015.

Exclusion Criteria

* Glasgow Coma Scale (GCS) \< 15
* No functioning of the optic nerve or retina in both eyes
* Unable to open both eyes
* Non communicating patients e.g. aphasia (incompetent patients)
* Unable to cooperate to the physical examinations
* Less than 2 weeks of hospitalization in the rehabilitation department
* If the sub investigator finds the study participant unfit to conduct the investigations
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Glostrup University Hospital, Copenhagen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Helle Klingenberg Iversen, MD, DmSc

MD, DMSc

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Helle K Iversen, MD, DMSc

Role: STUDY_CHAIR

Department of clinical stroke reseach, Department of Neurology, Glostrup Hospital.

Poul Jennum, MD, DMSc

Role: STUDY_DIRECTOR

Department Director of Danish Center for Sleep Medicine, Neurophysiological Department, Glostrup Hospital.

Anders S West, MD

Role: PRINCIPAL_INVESTIGATOR

Department of clinical stroke reseach, Department of Neurology, Glostrup Hospital.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of clinical stroke reseach, Department of Neurology, Glostrup Hospital.

Glostrup Municipality, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H-4-2013-114

Identifier Type: -

Identifier Source: org_study_id